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The present study was aimed to evaluate the malvidin’s protective effects on
damage induced by 30 min bilateral common carotid artery occlusion (BCCAO)
and 60 min reperfusion (RE) in rat pial microcirculation. Rat pial microcirculation
was observed using fluorescence microscopy through a closed cranial window.
Western blotting analysis was performed to investigate the endothelial nitric oxide
synthase (eNOS), phosphorylated eNOS (p-eNOS) and matrix metalloproteinase 9
(MMP-9) expression. Moreover, MMP-9 activity was evaluated by zymography. Finally,
neuronal damage and radical oxygen species (ROS) formation were assessed. In
all animals, pial arterioles were classified in five orders of branching according
to Strahler’s method. In hypoperfused rats, 30 min BCCAO and 60 min RE
caused a decrease in arteriolar diameter, an increase in microvascular leakage
and leukocyte adhesion, accompanied by decreased capillary perfusion and red
blood cell velocity (VRBC). Moreover, marked neuronal damage and evident ROS
generation were detected. Conversely, malvidin administration induced arteriolar
dilation in dose-related manner, reducing microvascular leakage as well as
leukocyte adhesion. Capillary perfusion and VRBC were protected. Nitric oxide
(NO) synthase inhibition significantly attenuated malvidin’s effects on arteriolar
diameter. Western blotting analysis revealed an increase in eNOS and p-eNOS
expression, while zymography indicated a decrease in MMP-9 activity after malvidin’s
administration. Furthermore, malvidin was able to prevent neuronal damage and to
decrease ROS generation. In conclusion, malvidin protects rat pial microcirculation
against BCCAO/RE injury, preventing blood-brain impairment and neuronal loss.
Malvidin’s effects appear to be mediated by eNOS activation and scavenger
activity.
Keywords: bilateral common carotid artery occlusion, reperfusion, pial microcirculation, endothelial nitric oxide
synthase, metalloproteinases, zymography, radical oxygen species, malvidin
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INTRODUCTION
Several studies indicate that pial microvascular changes during
hypoperfusion and reperfusion (RE) injury can mimic the
alterations in cerebral microcirculation during ischemic insults
(Lapi et al., 2008b, 2015). Pial arterioles, indeed, are the
main site of blood flow control to the superficial layer of
cerebral cortex, while pial venules drain most of cerebral
cortex blood flow. In particular, haemodinamic changes
in pial microvascular network trigger complex mechanisms
involving blood brain barrier (BBB) integrity and consequent
influence on neurons and astrocytes (Iadecola, 2004; Lapi
et al., 2015). The experimental model of bilateral common
carotid artery occlusion (BCCAO) and RE permits to study
the early microvascular responses of pial vessels leading to
the BBB disruption. Previous data have shown that brain
hypoperfusion, induced by BCCAO, and subsequent RE cause
significant damages in pial microcirculation, characterized
by vasoconstriction, BBB impairment, leukocytes adhesion,
reduction in capillary perfusion and consequent neuronal
loss (Ywasaki et al., 1989 ; Yanpallewar et al., 2004).
In particular, BCCAO determines radical oxygen species
(ROS)/nitric oxide (NO) imbalance inducing oxidative stress
with subsequent reduced arteriolar diameter and venular wall
alterations. These changes are accompanied by interstitial edema
as indicated by leakage of fluorescent tracers (Lapi et al.,
2012, 2015; Mastantuono et al., 2015). Furthermore, vascular
injury during brain ischemia may be due to activation of
matrix metalloproteinase-9 (MMP-9). It is well known that
MMPs are secreted into the extracellular space, as inactive
zymogens, and successively activated; in particular, MMP-9
appears to be activated during ischemia. Moreover, some
pro-inflammatory cytokines (TNFα and IL-1β) as well as
ROS have been proven to trigger a significant increase in
MMP-9 expression (Lehmann et al., 2005; Hsieh and Yang,
2013). Therefore, ischemia-activated MMPs could degrade
the extracellular matrix, leading to the opening of the BBB
(Fujimura et al., 1999; Aoki et al., 2002; Candelario-Jalil et al.,
2009).
Our previous data, moreover, have shown that antioxidants,
widely present in nature, are effective in counteracting the vessel
wall damage, reducing microvascular leakage as well as leukocyte
adhesion along pial venular walls, thus facilitating tissue
perfusion (Lapi et al., 2015; Mastantuono et al., 2015). Many
studies have reported the antioxidant and anti-inflammatory
properties of antocyanins present in berries and grapes,
indicating they could be useful in many pathophysiological
conditions. Among these molecules, malvidin 3-O- glucoside
appears to be one of the most abundant (Quintieri et al.,
2013).
Up to day, no data have been reported on the
protective effects of malvidin against cerebral injury,
due to hypoperfusion and RE. Therefore, the aim of
the present study was to evaluate the protective effects
of malvidin on damage induced by BCCAO and RE in




Male Wistar rats, weighing 250–300 g (Harlan, Italy), were
randomly divided into two groups: sham-operated group
(S group) and hypoperfused group (Hypo group).
The animals of the S group, submitted to the same surgical
procedures as the other experimental group without BCCAO
and RE, were differentiated in three subgroups: (1) Sham-saline
subgroup (n = 14) received intravenous (i.v.) saline solution
(0.9% NaCl); (2) Sham-M2 subgroup (n= 5) was treated with i.v.
higher dosage malvidin, 18 mg/kg body weight (b.w.); (3) Sham-
L subgroup (n = 5) was administered with i.v. L-NIO, 10 mg/kg
b.w. All substances were administered twice at 40 min time-
interval.
Hypoperfused group, subjected to 30 min BCCAO and
60 min RE, was divided in the following subgroups: (1) Hypo
subgroup (n = 14) was treated with i.v. saline solution (0.9%
NaCl), injected 10 min before BCCAO and at the beginning
of RE; (2) Hypo-M1 and Hypo-M2 subgroups (n = 5 and
n = 14, respectively) received i.v. malvidin, 9 or 18 mg/kg
b.w., respectively, 10 min before BCCAO and at the beginning
of RE; (3) Hypo-L/M2 subgroup (n = 14) was treated with
i.v. L-NIO 10 mg/kg b.w., prior to i.v. higher dosage malvidin
(18 mg/Kg b.w.).
In Sham-saline, Hypo, Hypo-M2 and Hypo-L/M2 subgroups
five animals were used for microvascular studies, three rats
were utilized for western blotting analysis and zimography,
three animals were used to determine neuronal damage by
triphenyl tetrazolium chloride (TTC) staining and three rats were
submitted to 2’-7’-dichlorofluorescein-diacetate (DCFH-DA)
assay after RE. The remaining subgroups were submitted only to
microvascular studies.
Administration of Drugs
Malvidin solution was obtained dissolving 9 or 18 mg/Kg b.w.,
in 0.5 mL saline solution and i.v. infused (3 min) 10 min
before BCCAO and at the beginning of RE. In pilot experiments
malvidin was tested in different concentrations to choose the
dosages useful for the present study. Malvidin concentrations
less than 9 mg/kg b.w. did not exert significant effect on the
pial microcirculation, while doses above 18 mg/kg b.w. did not
significantly increase the protective effects observed in the rats
treated with malvidin at the dose of 18 mg/kg b.w. and subjected
to hypoperfusion and RE.
L-NIO (10mg/kg b.w.) was dissolved in 0.5 mL saline solution
and i.v. administered 10 min prior to i.v. higher dosage
malvidin (18 mg/kg b.w.), 10 min before BCCAO and at the
beginning of RE. Pilot experiments indicated that the dosages
of L-NIO utilized in the present study abolished dilation of
rat pial arterioles caused by intravenous infusion of L-arginine,
10 mg/4 min (diameter increase by 23 ± 3% of baseline) or
blunted vasodilation due to topical application of acetylcholine,
100 µM (diameter increase by 4± 1% of baseline).
Drugs were administered according to the protocol previously
reported (Lapi et al., 2015). DCFH-DA was mixed with
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artificial cerebrospinal fluid (aCSF) to obtain a concentration
of 250 mM (Watanabe, 1998). This solution was superfused
over the pial surface for 30 min at the beginning of RE. All
drugs were purchased from Sigma Chemical, St. Louis, MO,
USA.
Animal Preparation
All experiments conform to the Guide for the Care
and Use of Laboratory Animals published by the USA
National Institutes of Health (NIH Publication No. 85–23,
revised 1996) and to institutional rules for the care and
handling of experimental animals. The protocol was
approved by the ‘‘Federico II’’ University of Naples Ethical
Committee.
Rats were anesthetized with an initial intraperitoneal
injection (i.p.) of α-chloralose (60 mg/kg b.w.) and maintained
by repeated intravenous injections (i.v.) of α-chloralose
(30 mg/kg b.w. every hour). Animals were paralyzed with
tubocurarine chloride (1 mg/kg.h, i.v.), tracheotomized and
mechanically ventilated with room air and supplemental
oxygen. The right and left common carotid arteries were
isolated for successive clamping. A catheter was placed in
the left femoral artery to measure arterial blood pressure;
the one in the right femoral vein for drug and fluorescent
tracer injection [fluorescein isothiocyanate bound to dextran,
molecular weight 70 kDa (FD 70), 50 mg/100 g b.w., as
5% wt/vol solution in 3 min administered just once at the
beginning of experiment after 30 min of the preparation
stabilization; rhodamine 6G, 1 mg/100 g b.w. in 0.3 mL, as a
bolus with supplemental injection throughout BCCAO and
RE (final volume 0.3 mL·100 g−1·h−1) to label leukocytes
for adhesion evaluation]. Blood gas measurements were
carried out on arterial blood samples withdrawn from arterial
catheter at 30 min time period intervals (ABL5; Radiometer,
Copenhagen, Denmark). Throughout all experiments, mean
arterial blood pressure, heart rate, respiratory CO2 and
blood gases values were recorded and stable settled within
physiological ranges. Rectal temperature was monitored and
preserved at 37.0 ± 0.5◦C, as previously reported (Lapi et al.,
2015).
To observe the pial microcirculation, a closed cranial window
(4 mm × 5 mm) was implanted above the left frontoparietal
cortex (posterior 1.5 mm to bregma; lateral, 3 mm to the
midline, according to the method previously described (Ngai
et al., 1988). Briefly, a 1 cm incision was made in the skin
to expose the skull and a craniotomy was performed. Cold
saline solution was suffused on the skull during drilling to
avoid overheating of cerebral cortex. The dura mater was gently
removed and a 150-µm-thick quarz microscope coverglass was
sealed to the bone with dental cement. The brain parenchyma
was continuously superfused with artificial cerebrospinal fluid
(aCSF; Hudetz et al., 1985; Morii et al., 1986). The rate of
superfusion was 0.5 mL/min controlled by a peristaltic pump.
The composition of the aCSF was 119.0 mM NaCl, 2.5 mM
KCl, 1.3 mM mgSO4·7H2O, 1.0 mM NaH2PO4, 26.2 mM
NaHCO3, 2.5 mM CaCl2 and 11.0 mM glucose (equilibrated
with 10.0% O2, 6.0% CO2 and 84.0% N2; pH 7.38 ± 0.02).
The temperature was maintained at 37.0 ± 0.5◦C with a water
bath.
Two atraumatic microvascular clips were placed on common
carotid arteries, previously isolated, to obtain the hypoperfusion.
After 30 min, they were removed to observe the pial
microcirculation in the RE period (60 min).
Fluorescence Intravital Microscopy
Pial vessels were observed with a fluorescent microscope
(Leitz Orthoplan, Wetzlar, Germany) fitted with long-
distance objectives (2.5×, numerical aperture (NA) 0.08;
10×, NA 0.20; 20×, NA 0.25; 32×, NA 0.40) a 10× eyepiece
and a filter block (Ploemopak, Leitz). Epiillumination
was provided by a 100-Watt mercury lamp using the
appropriate filters for FITC, for rhodamine 6G, and a
heat filter (Leitz KG1). The pial microcirculation was
televised with a DAGE MTI 300 low-light level digital
camera and recorded by a computer based frame grabber
(Pinnacle DC 10 plus, Avid Technology, Burlingtton, MA,
USA).
Geometric Analysis of Arteriolar Network
Under baseline conditions, the arteriolar network wasmapped by
stop-frame images and pial arterioles were classified according
to a centripetal ordering scheme (Strahler’s method, modified
according to diameter; Kassab et al., 1993; Lapi et al., 2008a).
Order 0 was assigned to the capillaries; thereafter, the terminal
arterioles were assigned order 1 and the vessels upstream were
assigned progressively higher order. When two vessels of the
same order joined, the parent vessel was assigned the next
highest order. If two daughter vessels were of different orders,
the parent vessel retained the higher of the two orders. In
each animal one order 4 arteriole, two order 3, and two order
2 arterioles were studied during each experiment. We studied
the responses of each arteriolar order to the experimental
conditions; however, we chose to present the data about order
3 vessels.
Microvascular Parameter Evaluation
Microvascular measurements were made off-line using a
computer-assisted imaging software system (MIP Image, CNR,
Institute of Clinical Physiology, Pisa, Italy). Recording of
microvascular images was performed for 1 min every 5 min
during baseline, before BCCAO and at the beginning of RE.
Afterwards, recording was carried out every 10 min during
BCCAO and the remaining RE. The baseline conditions were
represented by microvascular values detected within 2 min of
FITC administration.
Arteriolar diameters and capillary red blood cell velocity
(VRBC) were measured with a computer-assisted method (MIP
Image program, frame by frame). The results of diameter
measurements were in accord with those obtained by shearing
method (±0.5 µM). To avoid bias due to single operator
measurements, two independent ‘‘blinded’’ operators measured
the vessel diameters. Their measurements overlapped in all
cases.
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The increase in permeability was calculated and reported
as normalized gray levels (NGL): NGL = (I−Ir)/Ir, where, Ir
is the average baseline gray level at the end of vessel filling
with fluorescence (average of 5 windows located outside
the blood vessels with the same windows being used
throughout the experimental procedure), and I is the same
parameter at the end of BCCAO or at the end of RE. Gray
levels ranging from 0 to 255 were determined by the MIP
Image program in five regions of interest (ROI) measuring
50 × 50 µM (10× objective). The same location of ROI during
recordings along the microvascular networks was provided by a
computer-assisted device for XY movement of the microscope
table.
Adherent leukocytes (i.e., cells on vessel walls that did not
move over a 30-s observation period) were quantified in terms
of number/100 µM of venular length (v.l.)/30 s using higher
magnification (20× and 32×, microscope objectives). In each
experimental group 45 venules were studied.
Perfused capillary length (PCL) was measured by MIP image
in an area of 150 × 150 µM. In this system the length
of perfused capillaries is easily established by the automated
process because it is outlined by dextran (Colantuoni et al.,
2005).
Mean arterial blood pressure (Viggo-Spectramed P10E2
transducer; Oxnard, CA, USA—connected to a catheter in
the femoral artery) and heart rate were monitored with a
Gould Windograf recorder (model 13–6615–10S, Gould, OH,
USA). Data were recorded and stored in a computer. Blood
gas measurements were carried out on arterial blood samples
withdrawn from arterial catheter at 30 min time period intervals
(ABL5; Radiometer, Copenhagen, Denmark). The hematocrit
was measured under baseline conditions, at the end of BCCAO
and at the end of RE.
Western Blotting Analysis
Cortex and striatum tissues were homogenized in a Polytron
(Brinkman Instruments, NY, USA) in lysis buffer containing
50 mM HEPES, 150 mM NaCl, 5 mM EGTA, 150 mM
MgCl2, 1% glycerol, 1% Triton X-100, 1 mM PMSF, 1 mM
trypsin inhibitor. Protein concentration was quantified by
the Bradford assay (Bio-Rad, Berkeley, CA, USA). The
homogenate was stirred for 1 h at 4◦C and then centrifuged
at 14,000 rpm × 2′min. The supernatant was collected and
protein determined by the Bradford procedure (Bio-Rad,
Berkeley, CA, USA). Equal amounts of proteins were run on
7.5% SDS-PAGE under reducing conditions, then transferred
to polyvinylidene difluoride membranes (PVDF; Invitrogen,
Carlsbad, CA, USA). The membrane was blocked for 1 h
with 5% w/v BSA in Tris-buffered saline and 0.1% Tween
20 (TBST) at room temperature. Filters were incubated with
specific antibodies at 4◦C overnight, washed in TBST and then
incubated with horseradish peroxidase-conjugated secondary
antibody (1:1000; GE-Healthcare, Little Chalfont, UK) for 1 h
at room temperature. After washing, peroxidase activity was
detected by ECL system (GE-Healthcare, Little Chalfont, UK).
Protein loading was normalized by incubating the same filters
with anti-β-actin antibody (Sigma Aldrich; Milan, Italy) and
the band intensity was quantified by densitometry (ChemiDoc
XRS, Bio-Rad). We evaluated the protein concentration of
endothelial NO synthase (eNOS) and p/eNOS compared to
β/actin concentration and calculated the ratio p/eNOS/eNOS
concentrations.
To detect the proteins of interest, specific antibodies were
utilized: rabbit polyclonal anti-eNOS (1:1000), rabbit polyclonal
anti-phosphorylated eNOS (Ser1177) (1:1000) and anti-MMP-
9 (1:500). Anti-eNOS, anti-p-eNOS and anti-β-actin antibodies
were purchased from Cell Signaling Technology Inc., (Danvers,
MA, USA); while anti-MMP-9 antibody from Sigma-Aldrich
(St. Louis, MO, USA).
Gelatin Zymography
Equal amounts of proteins from each sample homogenate were
mixed with sample buffer (10 mM Tris-HCl pH 6.8, 12.5% SDS,
5% sucrose, 0.1% bromophenol blue) and subjected to SDS-
PAGE in 7.5% polyacrylamide gels, containing 0.1% (w/v) of
gelatine. After removal of SDS from the gels by incubation in
2.5% (w/v) Triton X-100 for 1 h, the gels were incubated at
37◦C for 18 h in 50 mM Tris-HCl pH 7.6 containing 0.2 M
NaCl, 5 mM CaCl2 and 0.02% (w/v). Gels were stained in
30% methanol, 10% glacial acetic acid containing 0.5% (w/v)
Coomassie Brilliant Blue G 250 for 1 h and destained in the
same solution without dye for several hours. The gelatinolytic
activity of each collagenase was evident as a clear band against the
blue background of stained gelatine. The molecular size of bands
displaying enzymatic activity were identified by comparison with
prestained standard protein, as well as with purified gelatinase A
or gelatinase B.
TTC Staining
Rats were sacrificed after 30 min BCCAO and 60 min RE. Tissue
damage was evaluated by TTC staining. The brains were cut into
1 mM coronal slices with a vibratome (Campden Instrument,
752 M; Lafayette, IN, USA). Sections were incubated in 2%
TTC for 20 min at 37◦C and in 10% formalin overnight. The
necrotic area site and extent in each section were evaluated by
image analysis software (Image-Pro Plus; Rockville, MD, USA;
Bederson et al., 1986).
DCFH-DA Assay
Artificial cerebrospinal fluid containing 250 mM DCFH-DA
at 37.0 ± 0.5◦C was superfused over the pial surface. DCFH-
DA is widely used as a marker for oxidative stress of the
cell and tissue (Wang and Joseph, 1999). This hydrophobic
non-fluorescent molecule penetrates rapidly into the cell, where
it is hydrolyzed to DCFH by intracellular esterases. Successively,
DCFH was oxidized to its fluorescent product (DCF) in
the presence of ROS. The intensity of DCF fluorescence is
proportional to the intracellular ROS level. The fluorescence
intensity was determined by the use of an appropriate
filter (522 nm) and estimated by NGL, comparing the DCF
fluorescence at the end of RE with the baseline represented
by pial surface just superfused by DCFH-DA (Watanabe,
1998).
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TABLE 1 | Variations of the main parameters at the end of reperfusion in sham-operated (Sham-saline) subgroup; hypoperfused (Hypo) subgroup;
malvidin (Hypo-M1) subgroup (9 mg/kg b.w.); higher dose malvidin (Hypo-M2) subgroup (18 mg/kg b.w.); L-NIO (10 mg/kg b.w) and malvidin (18 mg/kg
b.w.) subgroup.
Subgroups Number Microvascular Leukocyte adhesion Capillary perfusion Capillary red
of leakage (number of leukocyte/ (PCL) % reduction blood cell
animals (n) (NGL) 100 µm of venular (compared to baseline) velocity (VRBC mm/s)
length/30 s)
Sham-saline 5 0.03 ± 0.01 0.5 ± 0.3 0 ± 4 0.20 ± 0.02
Hypo 5 0.46 ± 0.04§◦ 10 ± 2§◦ 48 ± 4§◦ 0.12 ± 0.03§◦
Hypo-M1 5 0.32 ± 0.03§◦∗ 6 ± 1§◦∗ 35 ± 3§◦∗ 0.17 ± 0.01§◦∗
Hypo-M2 5 0.10 ± 0.02§◦∗ 2 ± 1∗ 28 ± 4§◦∗ 0.19 ± 0.02∗
Hypo-L/M2 5 0.13 ± 0.03§◦∗+ 3.0 ± 1.5∗ 30 ± 2§◦∗+ 0.24 ± 0.02∗
For capillary perfusion, data at the end of reperfusion were compared with those prior to hypoperfusion. Leukocyte adhesion: n = 45 venules for each entry. Data are
reported as Mean ± SEM; §p < 0.01 vs. Baseline; ◦p < 0.01 vs. Sham-saline subgroup, ∗p < 0.01 vs. Hypo subgroup, +p < 0.01 vs. Hypo-M2 subgroup.
Statistical Analysis
All data were expressed as Mean ± SEM. Data were
tested for normal distribution with the Kolmogorov-Smirnov
test. Parametric (Student’s t tests, ANOVA and Bonferroni
post hoc test) or nonparametric tests (Wilcoxon, Mann-
Whitney and Kruskal-Wallis tests) were used; nonparametric
tests were applied to compare diameter and length data
among experimental groups. Due to the small sample size
of DCFH-DA treated rats we used non-parametric tests to
compare the results obtained in these animals. The statistical
analysis was carried out by SPSS 14.0 statistical package
(IBM Italia, Segrate, Italy). Statistical significance was set at
p< 0.05.
RESULTS
Under baseline conditions, pial microvascular networks of all
animals were characterized by Strahler’s centripetal ordering
scheme, as previously reported (Lapi et al., 2008b): arterioles
were classified from the largest vessels, assigned order 5 (average
diameter 63.7 ± 4.7 µm), to the smallest ones, assigned order 1
(average diameter: 16.4 ± 2.3 µm). Capillaries, sprouting from
order 1 arterioles, were assigned order 0.
During the entire observation period, Sham-saline
subgroup did not show changes in arteriolar diameter, nor
microvascular leakage (0.03 ± 0.01 NGL), nor leukocyte
adhesion (0.5 ± 0.3/100 µm of venular length, v.l./30 s). All
capillaries were perfused and VRBC was 0.20 ± 0.02 mM/s
(Table 1, Figure 1B).
In Sham-M2 subgroup, malvidin treatment determined a
dose-related dilation of all arterioles; order 3 arterioles (average
mean diameter: 34.2 ± 3.2 µm) dilated by 4.5 ± 0.4% of
baseline with higher dosage malvidin. After drug treatment,
there were no significant changes in the other parameters when
compared to baseline. Conversely, L-NIO administration caused
no significant changes in all parameters.
Hypoperfusion and Reperfusion
BCCAO caused severe injuries in the pial microvascular
networks. The animals (Hypo subgroup) showed a decrease
in diameter of all arteriolar orders after 30 min BCCAO: the
reduction was by 15.0 ± 2.5% of baseline in order 3 vessels
(p < 0.01 vs. baseline and Sham-saline subgroup; Figure 1A).
Microvascular leakage significantly increased compared with
baseline (0.32± 0.04 NGL; p< 0.01 vs. baseline and Sham-saline
subgroup) (Figure 1C).
At RE, order 3 arteriole diameter (average mean diameter:
33.9 ± 2.7 µm) decreased by 9.6 ± 1.5% of baseline (p < 0.01
vs. baseline and Sham-saline subgroup; Figure 1A), while
microvascular leakage increased (0.46 ± 0.04 NGL; p < 0.01 vs.
baseline and Sham-saline subgroup). Moreover, the number of
leukocytes adhering to venular walls increased (10 ± 2/100 µm
v.l./30 s; p < 0.01 vs. baseline and Sham-saline subgroup); PCL
decreased by 48± 4% of baseline and VRBC was 0.12± 0.03mm/s
(p < 0.01 vs. baseline and Sham-saline subgroup; Table 1,
Figure 1D).
Conversely, Hypo-M1 subgroup, treated with lower dosage
malvidin (9 mg/kg b.w.), did not show significant change
in arteriolar diameter compared to baseline after 30 min
BCCAO (p < 0.01 vs. Hypo subgroup; Figure 1A), while
fluorescent spots along venular walls were significantly
reduced compared to animals of Hypo subgroup (0.18 ± 0.02
NGL; p < 0.01 vs. baseline, Sham-saline and Hypo
subgroups).
At RE, Hypo-M1 subgroup showed a significant increase in
arteriolar diameter: order 3 arterioles (average mean diameter:
33.7 ± 2.9 µm) dilated by 11.9 ± 1.8% of baseline (p < 0.01
vs. baseline, Sham-saline and Hypo subgroups; Figure 1A).
Furthermore, microvascular permeability significantly decreased
compared to animals of Hypo subgroup (0.32 ± 0.03 NGL;
p< 0.01 vs. baseline, Sham-saline andHypo subgroups) as well as
leukocyte adhesion (6± 1/100 µm v.l./30 s; p< 0.01 vs. baseline,
Sham-saline and Hypo subgroups). Finally, PCL diminished
by 35 ± 3% of baseline and VRBC was 0.17 ± 0.01mm/s
(p < 0.01 vs. baseline, Sham-saline and Hypo subgroups;
Table 1).
Hypo-M2 subgroup received higher dosage malvidin
(18 mg/kg b.w.) and revealed a significant dilation in
arteriolar diameter: order 3 arterioles (average mean diameter:
33.8 ± 2.8 µm) dilated by 16.5 ± 2.9% of baseline at the
end of BCCAO (p < 0.01 vs. baseline, Sham-saline and Hypo
subgroups; Figure 1A). Microvascular permeability did not
change compared to baseline (0.05 ± 0.01 NGL; p < 0.01 vs.
Hypo subgroup).
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FIGURE 1 | Diameter changes in the experimental subgroups (A). Diameter changes of order 3 arterioles, expressed in percentage of baseline at the end of
bilateral common carotid artery occlusion (BCCAO) and reperfusion (RE) in Sham-saline = sham operated subgroup; Hypo = hypoperfused subgroup;
Hypo-M1 = malvidin subgroup treated with lower dosage (9 mg/kg b.w.); Hypo-M2 = malvidin subgroup treated with higher dosage (18 mg/kg b.w.);
Hypo-L/M2 = L-NIO (10 mg/kg b.w.) and higher dosage malvidin (18 mg/kg b.w.) subgroup. Data are reported as Mean ± SEM; §p < 0.01 vs. Baseline; ◦p < 0.01
vs. Sham-saline subgroup; ∗p < 0.01 vs. Hypo subgroup at the end of BCCAO; ∗∗p < 0.01 vs. Hypo subgroup at the end of RE; +p < 0.01 vs. Hypo-M2 subgroup
at the end of BCCAO; ++p < 0.01 vs. Hypo-M2 subgroup at the end of RE. Computer-assisted images of a pial microvascular network under baseline conditions
(B), at the end of BCCAO (C) and RE (D) in one of the hypoperfused rats. The increase in microvascular leakage is outlined by the marked change in the color of
interstitium (from black to white). Computer-assisted images of a pial microvascular network under baseline conditions (E) at the end of BCCAO (F) and RE (G) in a
higher dosage malvidin-treated rat (18 mg/kg b.w.), where there was nitric oxide (NO) leakage of fluorescent-dextran.
At RE, the arteriolar diameter dilation was by 34.1 ± 3.2%
of baseline (p < 0.01 vs. baseline, Sham-saline and Hypo
subgroups; Figures 1A–G); moreover, microvascular leakage
was slightly increased (0.10 ± 0.02 NGL; p < 0.01 vs.
baseline, Sham-saline and Hypo subgroups) as well as leukocyte
adhesion (2 ± 1/100 µm v.l./30 s; p < 0.01 vs. Hypo
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FIGURE 2 | Western blotting of endothelial NO synthase (eNOS; A), phosphorylated eNOS (B) and MMP-9 (C) expression in two cerebral zones,
(Continued)
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FIGURE 2 | Continued
cortex (ctx) and striatum (str), at the end of RE in Sham-saline = sham
operated subgroup; Hypo = hypoperfused subgroup;
Hypo-M2 = malvidin subgroup treated with higher dosage (18 mg/kg
b.w.); Hypo-L/M2 = L-NIO (10 mg/kg b.w.) and higher dosage malvidin
(18 mg/kg b.w.) subgroup. Data are reported as Mean ± SEM; ◦p < 0.01
vs. Sham-saline subgroup, ∗p < 0.01 vs. Hypo subgroup.
subgroup). Finally, PCL decreased by 28 ± 4% of baseline
(p < 0.01 vs. baseline, Sham-saline and Hypo subgroups) and
VRBC was 0.19 ± 0.02 mm/s (p < 0.01 vs. Hypo subgroup;
Table 1).
Hypo-L/M2 subgroup, treated with L-NIO (10 mg/kg
b.w.) prior to the higher dosage malvidin administration,
showed a significant reduction in diameters of all arteriolar
orders compared to Hypo-M2 subgroup at the end of
BCCAO: order 3 arteriolar diameter (average mean diameter:
33.9 ± 3.1 µm) decreased by 6.4 ± 1.2% of baseline
(p < 0.01 vs. Hypo-M2 subgroup; Figure 1A). Microvascular
permeability did not significantly change compared to Hypo-
M2 subgroup (0.10 ± 0.02 NGL; p < 0.01 vs. Hypo
subgroup).
At RE, order 3 arteriole diameter was reduced by 5.5 ± 1.2%
of baseline (p < 0.01 vs. Hypo-M2 subgroup; Figure 1A); in
addition, fluorescent leakage was slightly increased (0.13 ± 0.03
NGL; p< 0.01 vs. baseline, Sham-saline and Hypo subgroups) as
well as leukocyte adhesion (3.0 ± 1.5/100 µm v.l./30 s; p < 0.01
vs. Hypo subgroup). Finally, PCL was reduced by 30 ± 2% of
baseline (p< 0.01 vs. baseline, Sham-saline andHypo subgroups)
and VRBC was 0.24 ± 0.02 mM/s (p < 0.01 vs. Hypo subgroup;
Table 1).
eNOS and MMP-9 Expressions
Hypoperfusion and subsequent RE did not significantly
affect eNOS and p-eNOS expressions both in cortex and
striatum. eNOS and p-eNOS expression was increased
in rats belonging to Hypo-M2 subgroup and blunted in
rats of Hypo-L/M2 subgroup when compared to Hypo
subgroup (Figures 2A,B). Moreover, the ratio p-eNOS/eNOS
increased in Hypo-L/M2 subgroup, indicating an increase in
expression and activity of p-eNOS in the malvidin-treated
animals.
MMP-9 expression markedly increased in the cortex
of hypoperfused rats; conversely, the MMP-9 expression
significantly decreased in the cortex of animals treated with
higher dosage malvidin compared to not-treated hypoperfused
animals (p < 0.01 vs. Hypo subgroup). L-NIO did not
interfere with the protective effects exerted by malvidin on
the reduction in MMP-9 expression (p < 0.01 vs. Hypo
subgroup; Figure 2C).
Gelatin zymography analysis did not show MMP-9 activity
in sham-operated animals. After hypoperfusion/RE, MMP-9
activity was significantly increased in cortex and striatum
of Hypo subgroup compared to Sham-saline subgroup.
Conversely, MMP-9 activity was significantly reduced
in rats treated with higher dosage malvidin compared
FIGURE 3 | MMP-9 activity detected by gel zimography assay, in two
cerebral zones, cortex (ctx) and striatum (str), at the end of RE in
Sham-saline = sham operated subgroup; Hypo = hypoperfused
subgroup; Hypo-M2 = malvidin subgroup treated with higher dosage
(18 mg/kg b.w.), Hypo-L/M2 = L-NIO (10 mg/kg b.w.) and higher
dosage malvidin (18 mg/kg b.w.) subgroup. Line 9: standard. Data are
reported as Mean ± SEM; ◦ p < 0.01 vs. Sham-saline subgroup, ∗p < 0.01
vs. Hypo subgroup.
to not-treated hypoperfused animals (p < 0.01 vs. Hypo
subgroup).
Moreover, L-NIO i.v. infused prior to higher dosage malvidin
did not affect the protective effects of this anthocyanin on
MMP-9 activity (Figure 3).
Tissue Damage Evaluation and ROS
Quantification
The neuroprotective effects of malvidin were quantified by
evaluating damaged area after 30 min BCCAO and 60 min RE.
In Hypo subgroup, TTC staining showed marked lesions in
cortex and in striatum in the both hemispheres (Figure 4A).
However, hypoperfused rats treated with malvidin showed
neuronal damage significantly reduced compared to animals
belonging to Hypo subgroup (Figure 4B).
At the end of observations, DCFH-DA assay did not reveal
significant increase in DCF fluorescence intensity in Sham-saline
subgroup (0.04 ± 0.02 NGL). An increase in DCF fluorescence
intensity was observed in Hypo subgroup after DCFH-DA
superfusion, indicating marked ROS production (0.35 ± 0.03
NGL; p < 0.01 vs. Sham-saline subgroup). On the other hand,
DCF fluorescence intensity was reduced in hypoperfused rats
treated with malvidin compared to animals belonging to Hypo
subgroup (Hypo-M2: 0.07 ± 0.01 NGL; p < 0.01 vs. Hypo
subgroup). Finally, there was no difference in DCF fluorescence
in rats treated with L-NIO prior to higher dosage malvidin
administration, compared to animals belonging to Hypo-M2
subgroup (0.09 ± 0.03 NGL; p < 0.01 vs. Hypo subgroup;
Figure 5).
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FIGURE 4 | Triphenyl tetrazolium chloride, (TTC) staining of coronal brain slices from a rat submitted to BCCAO and RE (A). TTC staining of coronal
brain slices from a rat treated with higher dose malvidin (18 mg/kg b.w.) (B). The lesion in the striatum is outlined by the dashed black line.
DISCUSSION
The results of the present study indicate that 30 min BCCAO
and subsequent 60 min RE caused marked alterations in
the rat pial microcirculation, determining BBB disruption
and significant neuronal damage. In hypoperfused animals,
a significant decrease in arteriolar diameter, indeed, was
accompanied by several microvascular impairments, including
increase in venular fluorescent leakage and leukocyte adhesion,
reduction in capillary perfusion and in capillary red blood cell
velocity. Therefore, hypoperfusion by bilateral common carotid
occlusion and RE were able to induce impaired vasomotor
tone, BBB permeability and tissue perfusion reduction,
triggering inflammatory mechanisms and affecting severely
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FIGURE 5 | DCF fluorescence intensity at the end of BCCAO and RE in
the different experimental groups: Sham-saline = sham operated
subgroup; Hypo = hypoperfused subgroup; Hypo-M2 = malvidin
subgroup treated with higher dosage malvidin (18 mg/kg b.w.);
Hypo-L/M2 = L-NIO (10 mg/kg b.w.) and malvidin (18 mg/kg b.w.)
subgroup. Data are reported as Mean ± SEM; ◦p < 0.01 vs. Sham-saline
subgroup, ∗p < 0.01 vs. Hypo subgroup.
pial microcirculation, as previously reported (Lapi et al., 2012,
2015; Mastantuono et al., 2015). These results are in accord
with the observations by Eklöf and Siesjö (1972, 1973), who
introduced this technique to investigate functional and structural
impairment in cerebral circulation.
On the other hand, malvidin prevented, in dose-
related manner, pial microvascular alterations, induced by
hypoperfusion-RE, causing a significant increase in arteriolar
diameter. This effect on arteriolar function was accompanied
by prevention of vessel wall integrity, as demonstrated by the
significant decrease in permeability, protection of capillary
perfusion, as proven by improved PCL, and recovery of
capillary red blood cell velocity, thus preventing marked
inflammation. To clarify the molecular mechanisms triggered
by the malvidin treatment, L-NIO, a specific eNOS inhibitor,
was administered prior to malvidin, blunting the arteriolar
dilation, but preserving the protective effects exerted by
malvidin on the other vascular parameters. These findings
allowed us to hypothesize a main role of eNOS in malvidin-
induced preservation of arteriolar functions. Western blotting
data support this hypothesis, demonstrating increased e-
NOS and p-eNOS expressions in malvidin-treated rats.
Moreover, the increase in the ratio p-eNOS/eNOS in the
animals treated with malvidin indicates that there was an
increase in expression and in activity of eNOS with the resultant
arteriolar dilation. These results are in accord with previous
studies carried out by Quintieri et al. (2013) who showed that
malvidin is able to increase Akt/eNOS phosphorylation and to
activate phosphatidylinositol-3-kinase (PI3-K)/NO/cGMP/PKG
pathway in cardiac extracts, eliciting cardioprotection against
ischemia/RE damage (Quintieri et al., 2013). Furthermore, our
data indicate that malvidin treatment was able to counteract ROS
production and neuronal loss, supporting the well known ROS
scavenger effects of malvidin (Kähkönen and Heinonen, 2003).
This molecule belonging to the family of anthocyanins, indeed,
exhibits antioxidant, anti-inflammatory, anti-carcinogenic, anti-
obesity and vasoprotective effects (Kähkönen and Heinonen,
2003; McGhie and Walton, 2007; He and Giusti, 2010).
Therefore, these natural organic compounds may contribute to
prevent the risk of chronic and degenerative diseases related to
oxidative stress (Lapi et al., 2012, 2015; Lapi and Colantuoni,
2015; Mastantuono et al., 2015) and appear to be effective in
preventing different pathophysiological conditions (Joseph
et al., 1999, 2003). The present data support our previous
observations that anthocyanins derived from Vaccinium
Mirtyllus are able to counteract microvascular impairments, due
to ischemia-RE in hamster cheek pouch model (Bertuglia et al.,
1995).
However, the novelty in the present study is represented
by the results on matrix metalloproteinase-9. This protelolytic
enzyme has been suggested to induce deleterious effects during
ischemia and RE injury. Lakhan et al. (2009) have shown that
MMP-9 is released in response to ischemic insult from neurons,
oligodendroglia, reactive astrocytes and activated microglia.
Successively, Yamashita and Abe (2011) demonstrated that
oxygen-derived free radicals, tissue-type plasminogen activator
and other molecules are released after ischemic insult and could
activate MMP-9 (Fagan et al., 2004; Yamashita and Abe, 2011).
The increase in MMP-9 is further associated with different
alterations, including excitotoxicity, neuronal damage (Lee et al.,
2004), apoptosis (Lee and Lo, 2004; Copin et al., 2005), oxidative
stress (Kelly et al., 2008), interference with oxidative DNA repair
mechanisms (Yang et al., 2010) and BBB opening, leading to
cerebral edema and hemorrhagic transformation (Zhao et al.,
2006) after cerebral ischemia.
Our data demonstrate that MMP-9 levels increased in cortex
after 30 min BCCAO and 60 min RE. This increase in MMP-9
expression was also accompanied by enhanced activity, both
in cortex and striatum, as observed using gelatin zimography
in hypoperfused animals. These data are in agreement with
previous observations carried out by Fujimura et al. (1999),
demonstrating increased MMP-9 expression and activity in
a murine model of MCAO. On the contrary, malvidin-
treatment appears to counteract MMP-9 expression and activity,
significantly decreased in malvidin-treated rats, where we did not
detect increased fluorescent leakage and interstitial edema.
The present data, according to our aims, demonstrate the
effects of malvidin during cerebral hypoperfusion and RE
injury utilizing a single molecule belonging to the anthocyanins.
Therefore, for the first time, our results indicate that this
natural antioxidant is able to reduce the expression of MMP-
9 and the consequent increase in BBB permeability. During
the last 20 years, MMP-9 has been identified as aberrantly
overactive in ischemia, potentially causing deleterious effects
during ischemia and after RE; therefore its inhibition has
been suggested as a potential therapeutic target (Dong et al.,
2009).
Clark et al. (1997) showed an increase in MMP-9 in
human brain after ischemia. They reported that MMP-9
activity was markedly elevated in the infarcted human cerebral
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tissue after 2 days post-infarction when compared to non-
infarcted tissue. Heo et al. (1999) used gelatin zymography
and demonstrated that 2 h occlusion of middle cerebral artery
caused transient increase in MMP-9, but did not affect MMP-2
activity.
Neuroprotection by MMP-9 inhibition or reduction
in cerebral ischemia has been attempted in multiple
studies during the last decade, using different strategies
for MMP-9 inhibition. Under different pathophysiological
conditions, MMP-9 inhibition has been proven to be
neuroprotective.
Our results confirm that inhibition of MMP-9 may be useful
in preventing cerebral edema, due to hypoperfusion and RE
injury.
In conclusion, the malvidin’s effects may be related to the
different mechanisms elicited by this anthocyanin: malvidin is
able to stimulate NO release, causing arteriolar dilation, and to
modulate eNOS, p-eNOS andMMP-9 expression. Consequently,
malvidin is able to reduce inflammatory processes and to protect
BBB integrity, contributing to the prevention of microvascular
and tissue changes, triggered by brain hypoperfusion-RE injury.
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